M&A Deal Summary |
|
|---|---|
| Date | 2020-07-16 |
| Target | GSK Consumer Healthcare - seven brands |
| Sector | Medical Products |
| Buyer(s) | Foundation Consumer Healthcare |
| Sellers(s) | GSK |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2014 |
| Sector | Medical Products |
Foundation Consumer Healthcare is dedicated to improving consumers’ lives by developing and growing a portfolio of differentiated over-the-counter (OTC) products. Foundation Consumer Healthcare was founded in 2014 and is based in Pittsburgh, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-09-18 |
Plan B One-Step
Petach Tikva, Israel Plan B One-Step comprises of value brands of emergency contraception, Take Action, Aftera, and Next Choice One Dose. |
Buy | $675M |
| Category | Company |
|---|---|
| Founded | 1715 |
| Sector | Life Science |
| Employees | 68,629 |
| Revenue | 31.4B GBP (2024) |
GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 24 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 21 of 23 |
| Country: United Kingdom M&A | 12 of 13 |
| Year: 2020 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-04-01 |
GlaxoSmithKline Consumer Healthcare
Gurugram, India GlaxoSmithKline Consumer Healthcare Ltd. is a consumer healthcare company that provides brands like Sensodyne, Eno, Crocin, and Otrivin. GlaxoSmithKline Consumer Healthcare is based in Gurugram, India. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-20 |
GlaxoSmithKline - The Clinical Laboratory Science
Marburg, Germany GlaxoSmithKline plc - The Clinical Laboratory Science consisting of approximately 80 scientists and analysts support the development of the future vaccine. |
Sell | - |